Causal Flows
are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators
and regulons
. In the causal flow, a mutation
may causally activate or deactivate a downstream regulator which then might up- down-regulates a regulon that contains genes with similar expression profiles and binding sites.
Causal Mechanistic Flows regulated by Mutation PRKG2_code_potential_somatic
ID | Mutation | Role | Regulator | Role | Regulon | # downstream regulons | # diffexp regulons | Drugs |
---|---|---|---|---|---|---|---|---|
CMF-25927 | PRKG2 | up-regulates | ZBTB16 | activates | R-2185 | 16 | 1 | Drugs (4) |
CMF-25933 | PRKG2 | down-regulates | ESR1 | represses | R-1188 | 7 | 2 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-25936 | PRKG2 | up-regulates | RFX2 | activates | R-2300 | 6 | 2 | Drugs (16) Regulator Drugs (0)Regulon Drugs (16)BEVACIZUMAB, CONBERCEPT, AMG-780, MEDI-3617, PEGAPTANIB SODIUM, TREBANANIB, PEGAPTANIB OCTASODIUM, MUPARFOSTAT, VANUCIZUMAB, RANIBIZUMAB, FARICIMAB, CVX-060, ABICIPAR PEGOL, NESVACUMAB, AFLIBERCEPT, BROLUCIZUMAB |
CMF-25938 | PRKG2 | down-regulates | POU4F2 | represses | R-2784 | 13 | 1 | Drugs (9) Regulator Drugs (0)Regulon Drugs (9)ATN-161, IMGN-388, CILENGITIDE, ABCIXIMAB, DIAZOXIDE, ETARACIZUMAB, INTETUMUMAB, STX-100, ABITUZUMAB |
CMF-42074 | PRKG2 | down-regulates | hsa-mir-326 | represses | R-2759 | 16 | 2 | Drugs (9) Regulator Drugs (0)Regulon Drugs (9)ATN-161, IMGN-388, CILENGITIDE, ABCIXIMAB, DIAZOXIDE, ETARACIZUMAB, INTETUMUMAB, STX-100, ABITUZUMAB |
CMF-42075 | PRKG2 | down-regulates | hsa-mir-326 | represses | R-1906 | 16 | 2 | Drugs (9) Regulator Drugs (0)Regulon Drugs (9)ATN-161, IMGN-388, CILENGITIDE, ABCIXIMAB, DIAZOXIDE, ETARACIZUMAB, INTETUMUMAB, STX-100, ABITUZUMAB |